论文部分内容阅读
目的观察探讨银杏达莫联合奥扎格雷钠治疗急性脑梗死的临床疗效,总结其临床用药经验和临床意义。方法选取我院2010年7月至2012年7月急性脑梗死的患者72例,按照数字表随机抽取方法分成观察组和对照组,各有36例,观察组使用银杏达莫联合奥扎格雷钠治疗,对照组使用血栓通注射液治疗,观察对比两组临床疗效。结果治疗15d后,观察组治疗总有效率为94.4%,对照组治疗总有效率为77.8%,两组疗效对比差异显著(P<0.05),具有统计学意义;两组神经功能缺损程度评分治疗后与治疗前对比均明显下降,观察组下降幅度更为明显(P<0.05),具有统计学意义。结论银杏达莫联合奥扎格雷钠治疗急性脑梗死的临床疗效显著,优于使用血栓通注射液治疗,可以有效缓解临床症状,改善神经功能,对改善预后有积极的临床意义。
Objective To investigate the clinical efficacy of gingko-damo combined with ozagrel sodium in the treatment of acute cerebral infarction and to summarize its clinical experience and clinical significance. Methods Seventy-two patients with acute cerebral infarction from July 2010 to July 2012 in our hospital were randomly divided into observation group and control group according to the digital table method, each with 36 cases in each group. The observation group was treated with ginkgo-dipaloxazole combined with ozagrel sodium The control group was treated with Xueshuantong Injection, and the clinical efficacy of the two groups was observed and compared. Results After 15 days of treatment, the total effective rate in the observation group was 94.4%, and the total effective rate in the control group was 77.8%. There was significant difference between the two groups (P <0.05), and there was significant difference between the two groups in neurological deficit score treatment After treatment and before treatment were significantly decreased, the observation group decreased more significantly (P <0.05), with statistical significance. Conclusion Ginkgo biloba combined with ozagrel sodium in the treatment of acute cerebral infarction clinical efficacy was significantly better than the use of Xueshuantong injection can effectively alleviate clinical symptoms and improve neurological function, and has a positive clinical significance of improving prognosis.